During the past decade, Inselspital Bern; Hämatologie und Hämatologisches Zentrallabor conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Inselspital Bern; Hämatologie und Hämatologisches Zentrallabor" #1 collaborator was "AbbVie" with 1 trials as a collaborator and "German CLL Study Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Inselspital Bern; Hämatologie und Hämatologisches Zentrallabor" are "Hemophilia A" (1 trials) and "Lymphocytic Leukemia, Chronic" (1 trials). Many other conditions were trialed in "Inselspital Bern; Hämatologie und Hämatologisches Zentrallabor" in a lesser frequency.

Most popular intervention types in "Inselspital Bern; Hämatologie und Hämatologisches Zentrallabor" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Chlorambucil" (1 trials), "Emicizumab" (1 trials), "Obinutuzumab" (1 trials) and "Venetoclax" (1 trials). Other intervention names were less common.

The vast majority of trials in "Inselspital Bern; Hämatologie und Hämatologisches Zentrallabor" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Inselspital Bern; Hämatologie und Hämatologisches Zentrallabor". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Inselspital Bern; Hämatologie und Hämatologisches Zentrallabor, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Inselspital Bern; Hämatologie und Hämatologisches Zentrallabor, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".